Table 4.
Patient preparation and PSMA-ligand administration
| Item | [68 Ga]Ga-PSMA-11 | [68 Ga]Ga-PSMA-I&T | [18F]F-DCFPyL | [18F]F-PSMA-1007 | [18F]F-rhPSMA-7.3 |
|---|---|---|---|---|---|
| Activity | 111–259 MBq (3–7 mCi) | 111–259 MBq (3–7 mCi) | 296–370 MBq (8–10 mCi) | 210–280 MBq (3–4 MBq/kg body mass) | 296 MBq (8 mCi) |
| Uptake time | 60 min (acceptable range: 50 to 100 min) | 60 min (acceptable range: 50 to 100 min) | 60 min | 90–120 min | 60 min |
| Consider hydration* and/or furosemide (20 mg intravenous) | Yes | Yes | Yes | No | No |
*e.g., oral intake of 1 L of water 1 h prior to acquisition